Notification letter and request form to non-registered holders
Filed with HKEX · Stock code 6628 · · 2 pages · English and Chinese
Summary by 6ix AI
Transcenta Holding Limited has issued a notification letter to non-registered holders regarding the publication of its interim report for a specific period. The letter provides instructions for non-registered holders on how to receive corporate communications either electronically or in printed form. It also includes a personal information collection statement related to the handling of personal data for processing requests.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Transcenta Holding Limited on 6ix
Earlier from Transcenta
- Notification letter and reply form to registered holders
- 2026 Interim report
- Transcenta Therapeutics Presents New Data for its Novel LIV1-Targeting ADC TST013 Demonstrating Potent Anti-Tumor Activity in PDX Models of Prostate Cancer and ER Positive /HER2 Negative Breast Cancer
- Transcenta Therapeutics Appoints Dr. Christopher Hwang as Head of Global Partnerships for HiCB Platform
- Transcenta Therapeutics to Present at the 36th Annual Oppenheimer Healthcare Life Sciences Conference
Later from Transcenta
- Cancellation and grant of award pursuant to the share incentive scheme
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Voluntary announcement-business update on the grant of China invention patents related to osemitamab (TST001) and its companion diagnostic antibody
- Voluntary announcement-receipt of the first payment in relation to the disposal of CDMO assets
- Update on measures and actions taken in resolving the disclaimer of opinion in the annual report for the year ended December 31, 2025
Follow Transcenta into a list and get an email when it puts out news.
Follow Transcenta